US$280 in China, US$8,892 in the US: new Chinese cancer drug gets FDA approval
www.scmp.com
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
  • lorty@lemmygrad.ml
    141·
    1 年前

    It’s just good business. If you commies knew how to do such gooddest deals you would be just as rich and love capitalism.